NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $392 | -48.6% | 8,865 | -35.4% | 0.04% | -51.9% |
| Q1 2023 | $762 | -99.8% | 13,720 | +38.5% | 0.08% | +170.0% |
| Q2 2022 | $351,000 | -54.3% | 9,907 | +28.3% | 0.03% | -63.9% |
| Q4 2020 | $768,000 | +155.1% | 7,722 | -13.5% | 0.08% | +186.2% |
| Q4 2019 | $301,000 | +1.7% | 8,932 | -16.7% | 0.03% | +70.6% |
| Q2 2019 | $296,000 | -3.9% | 10,719 | -34.6% | 0.02% | +21.4% |
| Q2 2018 | $308,000 | – | 16,380 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |